Receptors for advanced glycation end products is associated with autophagy in the clear cell renal cell carcinoma
dc.contributor.author | Guo, Yong | en_US |
dc.contributor.author | Zhang, Hai-Cong | en_US |
dc.contributor.author | Xue, Sheng | en_US |
dc.contributor.author | Zheng, Jun-Hua | en_US |
dc.date.accessioned | 2020-11-18T10:07:37Z | |
dc.date.available | 2020-11-18T10:07:37Z | |
dc.date.issued | 2019-04 | |
dc.description.abstract | Background: The receptor for advanced glycation end-product (RAGE) was one of the signal transduction receptors. RAGE interacted with various signaling molecules which were involved in human disease processes including tumorigenesis. Previous reports have indicated that RAGE/high-mobility group box 1 (HMGB1) could regulate autophagy in different carcinomas. However, the functional role of RAGE/ HMGB1 in the regulation of clear cell renal cell carcinoma (ccRCC) autophagy remained unrevealed. Methods: Western blot, quantitative real-time polymerase chain reaction (qRT-PCR) and immunofluorescence were used in the present study. Results: In this study, we demonstrated that the levels of RAGE/HMGB1 and autophagic protein LC3, Beclin-1, PI3K were much higher in ccRCC samples than those of in adjacent normal tissues. RAGE and autophagic protein expression was regulated with RAGE/HMGB1 in human RCC cell lines. Conclusion: Our results implicated that RAGE and autophagy played important roles in ccRCC, and RAGE/HMGB1 might serve as a novel therapeutic target for future ccRCC treatment | en_US |
dc.identifier.affiliations | Department of Urology, Shanghai Tenth People's Hospital of Nanjing Medical University, Nanjing; Transplantation Centre, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China | en_US |
dc.identifier.affiliations | Department of Pathology, The Fifth Hospital of Shijiazhuang, Shijiazhuang, China | en_US |
dc.identifier.affiliations | Department of Urology, Shanghai Tenth People's Hospital of Nanjing Medical University, Nanjing, China | en_US |
dc.identifier.affiliations | Department of Urology, Shanghai General Hospital of Nanjing Medical University, Nanjing; Department of Urology, The Affiliated First People's Hospital of Shanghai Jiao Tong University, Shanghai, China | en_US |
dc.identifier.citation | Guo Yong, Zhang Hai-Cong, Xue Sheng, Zheng Jun-Hua. Receptors for advanced glycation end products is associated with autophagy in the clear cell renal cell carcinoma. Journal of Cancer Research and Therapeutics. 2019 Apr; 15(2): 317-323 | en_US |
dc.identifier.issn | 0973-1482 | |
dc.identifier.place | India | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/213616 | |
dc.language | en | en_US |
dc.publisher | Wolters Kluwer India Pvt. Ltd. | en_US |
dc.relation.issuenumber | 2 | en_US |
dc.relation.volume | 15 | en_US |
dc.source.uri | https://dx.doi.org//10.4103/jcrt.JCRT_180_18 | en_US |
dc.subject | Autophagy | en_US |
dc.subject | clear cell renal cell carcinoma | en_US |
dc.subject | high-mobility group box 1 | en_US |
dc.subject | receptor for advanced glycation end-product | en_US |
dc.title | Receptors for advanced glycation end products is associated with autophagy in the clear cell renal cell carcinoma | en_US |
dc.type | Journal Article | en_US |
Files
Original bundle
1 - 1 of 1